- Report
- July 2026
- 324 Pages
Global
From €5296EUR$5,850USD£4,537GBP
- Report
- July 2026
- 151 Pages
Global
From €5296EUR$5,850USD£4,537GBP
- Report
- July 2026
- 381 Pages
Global
From €5296EUR$5,850USD£4,537GBP
- Report
- July 2026
- 215 Pages
Global
From €5296EUR$5,850USD£4,537GBP
- Report
- July 2026
- 412 Pages
Global
From €5296EUR$5,850USD£4,537GBP
- Report
- July 2026
- 217 Pages
Global
From €5296EUR$5,850USD£4,537GBP
- Report
- July 2026
- 350 Pages
Global
From €5296EUR$5,850USD£4,537GBP
- Report
- July 2026
- 376 Pages
Global
From €5296EUR$5,850USD£4,537GBP
- Report
- July 2026
- 281 Pages
Global
From €5296EUR$5,850USD£4,537GBP
- Report
- July 2026
- 194 Pages
Global
From €5296EUR$5,850USD£4,537GBP
- Report
- July 2026
- 196 Pages
Global
From €5296EUR$5,850USD£4,537GBP
- Report
- July 2026
- 296 Pages
Global
From €5296EUR$5,850USD£4,537GBP
- Report
- July 2026
- 415 Pages
Global
From €5296EUR$5,850USD£4,537GBP
- Report
- June 2026
- 110 Pages
Global
From €4300EUR$4,750USD£3,684GBP
- Report
- May 2026
- 350 Pages
Global
From €4480EUR$4,949USD£3,838GBP
- Report
- May 2026
- 350 Pages
Global
From €4480EUR$4,949USD£3,838GBP
- Report
- May 2026
- 350 Pages
Global
From €4480EUR$4,949USD£3,838GBP
- Report
- May 2026
- 400 Pages
Global
From €4480EUR$4,949USD£3,838GBP
- Report
- July 2025
- 350 Pages
Global
From €4480EUR$4,949USD£3,838GBP
- Report
- July 2025
- 350 Pages
Global
From €4480EUR$4,949USD£3,838GBP

The Contract Research Organization (CRO) market within the biotechnology sector is a rapidly growing industry. It provides services to biotechnology companies, such as drug discovery, preclinical and clinical trials, and regulatory affairs. CROs are often used to outsource research and development activities, allowing biotechnology companies to focus on their core competencies. CROs also provide access to specialized expertise and resources, such as specialized laboratory equipment and personnel.
CROs are increasingly being used to reduce costs and speed up the development process. They are also used to reduce the risk associated with drug development, as they can provide access to a wide range of expertise and resources.
Some of the major companies in the CRO market include Parexel, Quintiles, Charles River Laboratories, Covance, and PRA Health Sciences. Show Less Read more